By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
This report aims to provide a comprehensive presentation of the global market for mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Therapy. This report contains market size and forecasts of mRNA Therapy in global, including the following market information:
Global mRNA Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global mRNA Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of mRNA Therapy include Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca and CureVac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global mRNA Therapy Market Segment Percentages, by Type, 2022 (%)
Vaccine
Drugs
Global mRNA Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global mRNA Therapy Market Segment Percentages, by Application, 2022 (%)
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
Global mRNA Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global mRNA Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies mRNA Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Therapy, market overview.
Chapter 2: Global mRNA Therapy market size in revenue.
Chapter 3: Detailed analysis of mRNA Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 mRNA Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Therapy Overall Market Size
2.1 Global mRNA Therapy Market Size: 2022 VS 2029
2.2 Global mRNA Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Therapy Players in Global Market
3.2 Top Global mRNA Therapy Companies Ranked by Revenue
3.3 Global mRNA Therapy Revenue by Companies
3.4 Top 3 and Top 5 mRNA Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Therapy Players in Global Market
3.6.1 List of Global Tier 1 mRNA Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Therapy Market Size Markets, 2022 & 2029
4.1.2 Vaccine
4.1.3 Drugs
4.2 By Type - Global mRNA Therapy Revenue & Forecasts
4.2.1 By Type - Global mRNA Therapy Revenue, 2018-2023
4.2.2 By Type - Global mRNA Therapy Revenue, 2024-2029
4.2.3 By Type - Global mRNA Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Therapy Market Size, 2022 & 2029
5.1.2 mRNA Targeted Delivery in vivo
5.1.3 Genetically Modified T cells
5.1.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
5.1.5 Small Molecule Drugs Discovery
5.2 By Application - Global mRNA Therapy Revenue & Forecasts
5.2.1 By Application - Global mRNA Therapy Revenue, 2018-2023
5.2.2 By Application - Global mRNA Therapy Revenue, 2024-2029
5.2.3 By Application - Global mRNA Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global mRNA Therapy Market Size, 2022 & 2029
6.2 By Region - Global mRNA Therapy Revenue & Forecasts
6.2.1 By Region - Global mRNA Therapy Revenue, 2018-2023
6.2.2 By Region - Global mRNA Therapy Revenue, 2024-2029
6.2.3 By Region - Global mRNA Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America mRNA Therapy Revenue, 2018-2029
6.3.2 US mRNA Therapy Market Size, 2018-2029
6.3.3 Canada mRNA Therapy Market Size, 2018-2029
6.3.4 Mexico mRNA Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe mRNA Therapy Revenue, 2018-2029
6.4.2 Germany mRNA Therapy Market Size, 2018-2029
6.4.3 France mRNA Therapy Market Size, 2018-2029
6.4.4 U.K. mRNA Therapy Market Size, 2018-2029
6.4.5 Italy mRNA Therapy Market Size, 2018-2029
6.4.6 Russia mRNA Therapy Market Size, 2018-2029
6.4.7 Nordic Countries mRNA Therapy Market Size, 2018-2029
6.4.8 Benelux mRNA Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia mRNA Therapy Revenue, 2018-2029
6.5.2 China mRNA Therapy Market Size, 2018-2029
6.5.3 Japan mRNA Therapy Market Size, 2018-2029
6.5.4 South Korea mRNA Therapy Market Size, 2018-2029
6.5.5 Southeast Asia mRNA Therapy Market Size, 2018-2029
6.5.6 India mRNA Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America mRNA Therapy Revenue, 2018-2029
6.6.2 Brazil mRNA Therapy Market Size, 2018-2029
6.6.3 Argentina mRNA Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Therapy Revenue, 2018-2029
6.7.2 Turkey mRNA Therapy Market Size, 2018-2029
6.7.3 Israel mRNA Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia mRNA Therapy Market Size, 2018-2029
6.7.5 UAE mRNA Therapy Market Size, 2018-2029
7 mRNA Therapy Companies Profiles
7.1 Moderna
7.1.1 Moderna Company Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna mRNA Therapy Major Product Offerings
7.1.4 Moderna mRNA Therapy Revenue in Global Market (2018-2023)
7.1.5 Moderna Key News & Latest Developments
7.2 BioNTech
7.2.1 BioNTech Company Summary
7.2.2 BioNTech Business Overview
7.2.3 BioNTech mRNA Therapy Major Product Offerings
7.2.4 BioNTech mRNA Therapy Revenue in Global Market (2018-2023)
7.2.5 BioNTech Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer mRNA Therapy Major Product Offerings
7.3.4 Pfizer mRNA Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Arcturus Therapeutics Holdings Inc.
7.4.1 Arcturus Therapeutics Holdings Inc. Company Summary
7.4.2 Arcturus Therapeutics Holdings Inc. Business Overview
7.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Major Product Offerings
7.4.4 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue in Global Market (2018-2023)
7.4.5 Arcturus Therapeutics Holdings Inc. Key News & Latest Developments
7.5 Astrazeneca
7.5.1 Astrazeneca Company Summary
7.5.2 Astrazeneca Business Overview
7.5.3 Astrazeneca mRNA Therapy Major Product Offerings
7.5.4 Astrazeneca mRNA Therapy Revenue in Global Market (2018-2023)
7.5.5 Astrazeneca Key News & Latest Developments
7.6 CureVac
7.6.1 CureVac Company Summary
7.6.2 CureVac Business Overview
7.6.3 CureVac mRNA Therapy Major Product Offerings
7.6.4 CureVac mRNA Therapy Revenue in Global Market (2018-2023)
7.6.5 CureVac Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. mRNA Therapy Market Opportunities & Trends in Global Market
Table 2. mRNA Therapy Market Drivers in Global Market
Table 3. mRNA Therapy Market Restraints in Global Market
Table 4. Key Players of mRNA Therapy in Global Market
Table 5. Top mRNA Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global mRNA Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global mRNA Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies mRNA Therapy Product Type
Table 9. List of Global Tier 1 mRNA Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global mRNA Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - mRNA Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - mRNA Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global mRNA Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - mRNA Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - mRNA Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global mRNA Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global mRNA Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global mRNA Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America mRNA Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America mRNA Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe mRNA Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe mRNA Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia mRNA Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia mRNA Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America mRNA Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America mRNA Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa mRNA Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa mRNA Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Moderna Company Summary
Table 31. Moderna mRNA Therapy Product Offerings
Table 32. Moderna mRNA Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Moderna Key News & Latest Developments
Table 34. BioNTech Company Summary
Table 35. BioNTech mRNA Therapy Product Offerings
Table 36. BioNTech mRNA Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. BioNTech Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer mRNA Therapy Product Offerings
Table 40. Pfizer mRNA Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Arcturus Therapeutics Holdings Inc. Company Summary
Table 43. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Offerings
Table 44. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Arcturus Therapeutics Holdings Inc. Key News & Latest Developments
Table 46. Astrazeneca Company Summary
Table 47. Astrazeneca mRNA Therapy Product Offerings
Table 48. Astrazeneca mRNA Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Astrazeneca Key News & Latest Developments
Table 50. CureVac Company Summary
Table 51. CureVac mRNA Therapy Product Offerings
Table 52. CureVac mRNA Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. CureVac Key News & Latest Developments
List of Figures
Figure 1. mRNA Therapy Segment by Type in 2022
Figure 2. mRNA Therapy Segment by Application in 2022
Figure 3. Global mRNA Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global mRNA Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Therapy Revenue in 2022
Figure 8. By Type - Global mRNA Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global mRNA Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global mRNA Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global mRNA Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global mRNA Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global mRNA Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global mRNA Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America mRNA Therapy Revenue Market Share, 2018-2029
Figure 16. US mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe mRNA Therapy Revenue Market Share, 2018-2029
Figure 20. Germany mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia mRNA Therapy Revenue Market Share, 2018-2029
Figure 28. China mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America mRNA Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa mRNA Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE mRNA Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Moderna mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioNTech mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Astrazeneca mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CureVac mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
